Lutetium-177 Therapy for Prostate and Neuroendocrine Tumors: What Patients Should Know
🧬 Introduction: Precision Treatment for Complex Cancers In the evolving world of cancer care, Lutetium-177 (Lu-177) therapy has emerged as one of the most effective and targeted approaches for treating prostate cancer and neuroendocrine tumors (NETs). At RNM Centre for Nuclear Medicine & Molecular Imaging, Rohtak, this advanced radionuclide therapy [...]
